Sign in
4

Changes in Ownership

CAPRICOR THERAPEUTICS, INC. Filed Acc 0001593086-26-000006

EVP, GENERAL COUNSEL sold 25,000 shares at $30.12 ($752,935)

  • EVP, GENERAL COUNSEL acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Krasney Karen · EVP, GENERAL COUNSEL

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-31 Exercise or conversion : show line 1 in the form 10b5-1 +693 $1.39 $963 31,240 D
2026-03-31 Exercise or conversion : show line 2 in the form 10b5-1 +21,488 $3.74 $80,365 52,728 D
2026-03-31 Exercise or conversion : show line 3 in the form 10b5-1 +2,819 $3.18 $8,964 55,547 D
2026-03-31 Sale : show line 4 in the form 10b5-1 −25,000 $30.12 $752,935 30,547 D
Open-market sales · 25,000 sh · avg $30.12 · $752,935

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-03-31 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −693 2,807 D
2026-03-31 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −21,488 74,205 D
2026-03-31 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −2,819 81,261 D
Loading xslF345X06/form4-04012026_080410.xml…